KBC Group NV
- SEC CIK
- 0001411133
- Latest filing
- Aug 5, 2026
COLL holding history
Collegium Pharmaceutical, Inc in every 13F filed by KBC Group NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
COLL overviewAll 13F holders of COLLFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −658−100.0% | Sold out | Holders |
| Q1 2026 | 658 | $22.0K | <0.1% | +658 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −2,336−100.0% | Sold out | Holders |
| Q1 2025 | 2,336 | $70.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 2,336 | $67.0K | <0.1% | +982+72.5% | Added | Holders |
| Q3 2024 | 1,354 | $52.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,354 | $44.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,354 | $53.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1,354 | $42.0K | <0.1% | −285−17.4% | Reduced | Holders |
| Q3 2023 | 1,639 | $37.0K | <0.1% | −1,102−40.2% | Reduced | Holders |
| Q2 2023 | 2,741 | $59.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 2,741 | $66.0K | <0.1% | −614−18.3% | Reduced | Holders |
| Q4 2022 | 3,355 | $78.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3,355 | $54.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 3,355 | $59.0K | <0.1% | −15,366−82.1% | Reduced | Holders |
| Q1 2022 | 18,721 | $381.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 18,721 | $350.0K | <0.1% | +9,944+113.3% | Added | Holders |
| Q3 2021 | 8,777 | $173.0K | <0.1% | +8,777 | New | Holders |